We are live on
!
Find out more
LC
Lavaca Capital Portfolio holdings
AUM
$564M
1-Year Est. Return
4.6%
This Fund
S&P 500
This Quarter
Est. Return
-8.05%
1 Year Est. Return
-4.6%
3 Year Est. Return
+32.01%
5 Year Est. Return
+31.85%
10 Year Est. Return
–
AUM
$100M
AUM Growth
–
Cap. Flow
+$230M
Cap. Flow
% of AUM
228.61%
Top 10 Holdings %
Top 10 Hldgs %
52.49%
Holding
386
New
385
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$7.05M |
| 2 |
Merck
MRK
|
+$6.7M |
| 3 |
Altria Group
MO
|
+$5.83M |
| 4 |
Starbucks
SBUX
|
+$5.69M |
| 5 |
DuPont de Nemours
DD
|
+$5.36M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.91% |
| 2 | Healthcare | 13.28% |
| 3 | Consumer Staples | 13.07% |
| 4 | Energy | 11.57% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
British American Tobacco
BTI
$132B
| $55K | 0.05% |
+1,727
| New | +$67.2K |
|
|
NVO
127
Novo Nordisk
NVO
$216B
| $52K | 0.05% |
+2,256
| New | +$50.1K |
|
128
Sanofi
SNY
$104B
| $51K | 0.05% |
+1,168
| New | +$51.5K |
|
129
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $49K | 0.05% |
+630
| New | +$49K |
|
130
Ingredion
INGR
$6.38B
| $48K | 0.05% |
+528
| New | +$52.8K |
|
|
MRSH
131
Marsh
MRSH
$86.3B
| $48K | 0.05% |
+600
| New | +$50K |
|
132
Novartis
NVS
$295B
| $48K | 0.05% |
+631
| New | +$49.1K |
|
133
Southern Company
SO
$110B
| $48K | 0.05% |
+1,092
| New | +$49.6K |
|
|
CTRA
134
DELISTED
Coterra Energy
CTRA
| $45K | 0.04% |
+2,000
| New | +$48.3K |
|
135
Chemours
CC
$2.59B
| $44K | 0.04% |
+1,568
| New | +$49.6K |
|
136
HSBC
HSBC
$355B
| $44K | 0.04% |
+1,112
| New | +$44.5K |
|
137
Plains All American Pipeline
PAA
$17.4B
| $44K | 0.04% |
+2,174
| New | +$49.6K |
|
138
SAP
SAP
$187B
| $44K | 0.04% |
+440
| New | +$46.8K |
|
139
Deere & Co
DE
$170B
| $41K | 0.04% |
+277
| New | +$40.6K |
|
140
Capital One
COF
$124B
| $40K | 0.04% |
+525
| New | +$45.5K |
|
|
UN
141
DELISTED
Unilever NV New York Registry Shares
UN
| $39K | 0.04% |
+718
| New | +$39.2K |
|
142
GSK
GSK
$103B
| $37K | 0.04% |
+766
| New | +$37.7K |
|
143
PIMCO Corporate & Income Opportunity Fund
PTY
$2.48B
| $37K | 0.04% |
+2,400
| New | +$38.8K |
|
|
PFL
144
PIMCO Income Strategy Fund
PFL
$381M
| $36K | 0.04% |
+3,280
| New | +$36.1K |
|
|
PMF
145
DELISTED
PIMCO Municipal Income Fund
PMF
| $36K | 0.04% |
+2,880
| New | +$36K |
|
146
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $36K | 0.04% |
+2,244
| New | +$39.2K |
|
147
Targa Resources
TRGP
$60.4B
| $36K | 0.04% |
+1,000
| New | +$48.4K |
|
148
UBS Group
UBS
$170B
| $36K | 0.04% |
+2,876
| New | +$39K |
|
149
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
| $35K | 0.03% |
+1,380
| New | +$36.8K |
|
150
Ares Capital
ARCC
$13.5B
| $32K | 0.03% |
+2,075
| New | +$34.3K |
|
Similar funds
KBG
OC
AHSW
PEP
PSC
TCP
KF
AAS
Lavaca Capital's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Lavaca Capital, which disclosed 386 positions worth $100M. Its ten largest holdings account for 52% of the portfolio.
Its largest position is Intel: 150,601 shares worth $7.07M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Staples.
- Lavaca Capital's largest Q4 2018 buy was Intel: 150,601 shares worth $7.07M.
- Lavaca Capital's ten largest holdings make up 52% of its $100M portfolio in Q4 2018.
- Lavaca Capital disclosed 386 positions in Q4 2018, its first 13F filing on record.
Based on Lavaca Capital's 13F filing for Q4 2018, filed 22 Jan 2019.